Abstract:Integrins alpha9beta1 and alpha4beta1 form a distinct structural class, but while alpha4beta1 has been subjected to extensive study, alpha9beta1 remains poorly characterized. We have used the small molecule N-(benzenesulfonyl)-(L)-propyl-(L)-O-(1-pyrrolidinylcarbonyl)tyrosine (3) to investigate the biochemical properties of alpha9beta1 and directly compare these properties with those of alpha4beta1. Compound 3 has a high affinity for both integrins with K-D values of less than or equal to3 and 180 pM for alpha9beta1 in 1 mM Mn2+(activating) and 1 mM Ca2+ and 1 mM Mg2+ (nonactivating) conditions and less than or equal to5 and 730 pM for alpha4beta1 under the corresponding conditions. Ca2+ treatment promoted the binding of 3 to both integrins (EC50 = 30 muM Ca2+ in both cases). Compound 3 binding to both integrins was also stimulated by the addition of the activating monoclonal antibody TS2/16. These findings indicate that the mechanisms by which metal ions and TS2/16 regulate ligand binding to alpha9beta1 and alpha4beta1 are similar. The binding of 3 to both integrins induced the mAb 9EG7 LIBS epitope, a property consistent with occupancy of the receptor's ligand binding site by 3. But whereas EGTA treatment inhibited the binding of 9EG7 to alpha4beta1, it stimulated the binding of 9EG7 to alpha9beta1. The 9EG7 and TS2/16 effects point to contributions of the beta1-chains on binding. Crosslinking data revealed that the integrin alpha-chains are also involved in binding the small molecule, as stable linkages were observed on both the alpha9 chain of alpha9beta1 and the alpha4 chain of alpha4beta1. Extensive structure-activity analyses with natural and synthetic ligands indicate distinct features of the ligand binding pockets. Most notable was the estimated > 1000-fold difference in the affinity of the integrins for VCAM-1, which binds alpha4beta1 with an apparent K-D of 10 nM and alpha9beta1 with an apparent K-D of > 10 muM. Differences were also seen in the binding of a9 1 and a4 1 to osteopontin. Compound 3 competed effectively for the binding of VCAM-I and osteopontin to both integrins. While these studies show many similarities in the biochemical properties of alpha9beta1 and alpha4beta1, they identify important differences in their structure and function that can be exploited in the design of selective alpha9beta1 and alpha4beta1 inhibitors.

Induction of mouse β integrin expression following transfection with human α4 chain

Role Of Integrin Alpha-4-Beta-7/Alpha-4-Beta-P In Lymphocyte Adherence To Fibronectin And Vcam-1 And In Homotypic Cell Clustering

A humanized β2 integrin knockin mouse reveals localized intra- and extravascular neutrophil integrin activation in vivo

The Impact of Three-Dimensional Structure on the Expression of PlA Alloantigens on Human Integrin Beta 3.

Green fluorescent protein (GFP) tagged to the cytoplasmic tail of alphaIIb or beta3 allows the expression of a fully functional integrin alphaIIb(beta3): effect of beta3GFP on alphaIIb(beta3) ligand binding.

Identification of Ligand Binding Sites on Integrin Alpha 4 Beta 1 Through Chemical Cross-Linking

Structure-function analysis of the Abm12 beta mutation using site-directed mutagenesis and DNA-mediated gene transfer.

Fibrinogen Interaction Of Cho Cells Expressing Chimeric Alpha Iib/Alpha V Beta 3 Integrin

Immunobiological analysis of TCR single-chain transgenic mice reveals new possibilities for interaction between CDR3alpha and an antigenic peptide bound to MHC class I

Two modes of beta-receptor recognition are mediated by distinct epitopes on mouse and human interleukin-3

Activation Of Leukocyte Beta(2) Integrins By Conversion From Bent To Extended Conformations

Alpha 4 Beta 7 Integrin Mediates B Cell Binding to Fibronectin and Vascular Cell Adhesion Molecule-1. Expression and Function of Alpha 4 Integrins on Human B Lymphocytes.

The Integrin Alpha-Subunit Leg Extends At A Ca2+-Dependent Epitope In The Thigh/Genu Interface Upon Activation

Multiple ligand binding functions for VLA-2 α2β1 and VLA-3 (α3β1) in the integrin family

Conformation Coupling Between the I-like Domain Alpha7 Helix and the Hybrid Domain of Beta3 Integrins

Expression and function of alpha4/beta7 integrin on human natural killer cells

Multiple Activation States of Integrin Α4β1 Detected Through Their Different Affinities for a Small Molecule Ligand

[Construction of Human Integrin Beta3 Subunit Eukaryotic Expression Vector and Efficient Surface Expression of Integrin Alphaiibbeta3].

Fibrinogen Interaction of CHO Cells Expressing Chimeric Αiib/αvβ3 Integrin

Comparative Assessment of the Ligand and Metal Ion Binding Properties of Integrins Α9β1 and Α4β1

The integrin α-subunit leg extends at a Ca<sup>2+</sup>-dependent epitope in the thigh/genu interface upon activation